Biome Grow Stock Return On Equity

BIOIF Stock  USD 0.01  0  94.74%   
Biome Grow fundamentals help investors to digest information that contributes to Biome Grow's financial success or failures. It also enables traders to predict the movement of Biome Pink Sheet. The fundamental analysis module provides a way to measure Biome Grow's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biome Grow pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biome Grow Company Return On Equity Analysis

Biome Grow's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Biome Grow Return On Equity

    
  -4.37  
Most of Biome Grow's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biome Grow is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Biome Grow has a Return On Equity of -4.374. This is 81.75% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

Biome Fundamentals

About Biome Grow Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biome Grow's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biome Grow using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biome Grow based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Biome Pink Sheet

Biome Grow financial ratios help investors to determine whether Biome Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biome with respect to the benefits of owning Biome Grow security.